Gabriella Cirmena
Overview
Explore the profile of Gabriella Cirmena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tommasi S, Coppola C, Caniglia A, Pilato B, Zito F, Carosi M, et al.
Pathologica
. 2025 Jan;
116(5):303-309.
PMID: 39748712
Objective: Prostate cancer (PCa) is the most common cause of cancer-related deaths in men worldwide. BRCA1/2 genes are reported altered in approximately 1% and 8% of PCa cases, respectively. To...
2.
Rivera D, Paudice M, Accorsi G, Valentino F, Ingaliso M, Pianezzi A, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068290
Endometrial cancer (EC) is the most frequent gynecological cancer. The ESGO/ESTRO/ESP 2020 guidelines identify prognostic groups based on morpho-molecular characteristics. This study aims to evaluate the clinical applicability of NGS...
3.
Dameri M, Cirmena G, Ravera F, Ferrando L, Cuccarolo P, Stabile M, et al.
Crit Rev Oncol Hematol
. 2023 Mar;
185:103963.
PMID: 36931614
Liquid biopsy has the potential to drastically change clinical practice, paving the way to a novel non-invasive approach for cancer diagnosis and treatment. One of the limitations for the implementation...
4.
Sahnane N, Rivera D, Libera L, Carnevali I, Banelli B, Facchi S, et al.
J Mol Diagn
. 2023 Feb;
25(4):217-226.
PMID: 36739964
Epithelial ovarian cancers (EOCs) harboring germline or somatic pathogenic variants in BRCA1 and BRCA2 genes show sensitivity to poly(ADP-ribose) polymerase inhibition. It has been suggested that BRCA1 promoter methylation is...
5.
Rinchai D, Deola S, Zoppoli G, Kabeer B, Taleb S, Pavlovski I, et al.
Sci Adv
. 2022 Nov;
8(45):eabp9961.
PMID: 36367935
Knowledge of the mechanisms underpinning the development of protective immunity conferred by mRNA vaccines is fragmentary. Here, we investigated responses to coronavirus disease 2019 (COVID-19) mRNA vaccination via high-temporal resolution...
6.
Ravera F, Borea R, Cirmena G, Dameri M, Ferrando L, Gallo M, et al.
J Transl Med
. 2022 May;
20(1):230.
PMID: 35568887
Background And Rationale: Little is known about SARS-CoV-2 seroconversion in asymptomatic patients affected by solid cancer, and whether it is associated with specific transcriptomics changes in peripheral blood mononuclear cells...
7.
Cirmena G, Ferrando L, Ravera F, Garuti A, Dameri M, Gallo M, et al.
JCO Precis Oncol
. 2022 Feb;
6:e2100198.
PMID: 35201850
Purpose: The study of plasma cell-free DNA integrity (cfDI) has shown potential for providing useful information in neoplastic patients. The aim of this study is to estimate the accuracy of...
8.
Ravera F, Cirmena G, Dameri M, Gallo M, Vellone V, Fregatti P, et al.
BMJ Open
. 2022 Jan;
11(12):e054256.
PMID: 34972769
Introduction: Standard procedures aimed at the early diagnosis of breast cancer (BC) present suboptimal accuracy and imply the execution of invasive and sometimes unnecessary tissue biopsies. The assessment of circulating...
9.
Cirmena G, Dameri M, Ravera F, Fregatti P, Ballestrero A, Zoppoli G
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298675
Current approaches for cancer detection and characterization are based on radiological procedures coupled with tissue biopsies, despite relevant limitations in terms of overall accuracy and feasibility, including relevant patients' discomfort....
10.
Dameri M, Ferrando L, Cirmena G, Vernieri C, Pruneri G, Ballestrero A, et al.
Int J Mol Sci
. 2021 Jul;
22(13).
PMID: 34281208
Next-generation sequencing (NGS) is the technology of choice for the routine screening of tumor samples in clinical practice. In this setting, the targeted sequencing of a restricted number of clinically...